<DOC>
	<DOCNO>NCT01352819</DOCNO>
	<brief_summary>The objective study evaluate effectiveness Deep Brain Stimulation adjunctive treatment reduce symptom advance , levodopa-responsive Parkinson 's disease adequately controlled medication . It first study Parkinson patient outside US Deep Brain Stimulation system use constant current instead constant voltage use lead active electrode tip .</brief_summary>
	<brief_title>Post Market ( Libra/LibraXP System ) Deep Brain Stimulation ( DBS ) Parkinson 's Disease Study</brief_title>
	<detailed_description>This study design prospective , observational , non-randomized , multi-centered study 12 month duration implantation subject use control . The primary outcome assessment occur three month : however , subject follow one year . A comparison measure within person pre-treatment post-treatment performed . Also , pre-treatment post-treatment group mean standard deviation determine .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Subjects enrol study must meet follow inclusion criterion : 1 . Subject sign informed consent . 2 . Subject diagnose , neurologist , idiopathic Parkinson 's disease . 3 . Subject candidate surgery . 4 . Subject 18 80 year age . 5 . Subject history improvement Parkinson 's symptom direct result administer ldopa subject least 25 % improvement Unified Parkinson 's Disease Rating Scale ( UPDRS ) motor score subject diagnose tremordominant Parkinson 's disease . 6 . Subject stable antiParkinson 's disease medication least one month prior study enrollment . Subjects exclude study meet follow criterion : 1 . Subject major illness medical condition opinion physician would interfere participation study . 2 . Subject nontreated clinically significant depression significant psychiatric comorbidities . 3 . Subject condition require repeat MRI scan ; 4 . Subject condition require diathermy ; 5 . Subject anticoagulant medication unable interrupt time procedure . 6 . Subject history cranial surgery . 7 . Subject dementia interfere ability cooperate comply study requirement comprehend Informed Consent determine investigator . 8 . Subject abuse drug alcohol . 9 . Subject history seizure 10 . Subject confirmation diagnosis terminal illness associate survival &lt; 12 month . 11 . Female lactate childbearing potential positive urine pregnancy test use adequate birth control . 12 . Subject participated drug , device biological trial within precede 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>